23 Jan Life Edit Therapeutics
Posted at 17:41h
in
Clare Murray, Ph.D., Senior Vice President, Corporate Development and Operations
April 13 | 2:30pm | Dark Horse Consulting Ballroom
Durham, NC
(Private)
Life Edit Therapeutics, an ElevateBio company, has a mission to deliver any edit, anywhere to pave the way to faster and safer gene editing therapeutics that cure disease and improve patient lives. We have developed a gene editing platform with unique RNA-guided nucleases (RGNs), base editors, and next-gen editing capabilities which we have validated both ex vivo in a number of relevant cell types, and in vivo in liver and CNS. Life Edit is developing a pipeline of ex vivo edited cell therapies and in vivo gene editing therapies, both wholly owned and through partnerships.
